These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30923955)

  • 21. Current perspective on rituximab in rheumatic diseases.
    Schioppo T; Ingegnoli F
    Drug Des Devel Ther; 2017; 11():2891-2904. PubMed ID: 29042750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin.
    MacIsaac J; Siddiqui R; Jamula E; Li N; Baker S; Webert KE; Evanovitch D; Heddle NM; Arnold DM
    Transfusion; 2018 Nov; 58(11):2729-2735. PubMed ID: 30244480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of granulomatosis with polyangiitis and pyoderma gangrenosum successfully treated with infliximab and rituximab.
    Donmez S; Pamuk ON; Gedik M; A K R; Bulut G
    Int J Rheum Dis; 2014 May; 17(4):471-5. PubMed ID: 24460826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of rituximab-induced interstitial pneumonitis observed in systemic lupus erythematosus.
    Kishi J; Nanki T; Watanabe K; Takamura A; Miyasaka N
    Rheumatology (Oxford); 2009 Apr; 48(4):447-8. PubMed ID: 19202159
    [No Abstract]   [Full Text] [Related]  

  • 25. [Rituximab for treatment of patients with systemic autoimmune diseases].
    García Hernández FJ; Ocaña Medina C; González León R; Garrido Rasco R; Colorado Bonilla R; Castillo Palma MJ; Sánchez Román J
    Med Clin (Barc); 2007 Mar; 128(12):458-62. PubMed ID: 17408540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extensive Pyoderma Gangrenosum Associated With Granulomatosis With Polyangiitis With Both Responsive to Rituximab.
    Murthy RK; Jackson J; Chatham WW; Sami N
    J Clin Rheumatol; 2016 Oct; 22(7):393-5. PubMed ID: 27660945
    [No Abstract]   [Full Text] [Related]  

  • 27. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
    Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID).
    Tony HP; Burmester G; Schulze-Koops H; Grunke M; Henes J; Kötter I; Haas J; Unger L; Lovric S; Haubitz M; Fischer-Betz R; Chehab G; Rubbert-Roth A; Specker C; Weinerth J; Holle J; Müller-Ladner U; König R; Fiehn C; Burgwinkel P; Budde K; Sörensen H; Meurer M; Aringer M; Kieseier B; Erfurt-Berge C; Sticherling M; Veelken R; Ziemann U; Strutz F; von Wussow P; Meier FM; Hunzelmann N; Schmidt E; Bergner R; Schwarting A; Eming R; Hertl M; Stadler R; Schwarz-Eywill M; Wassenberg S; Fleck M; Metzler C; Zettl U; Westphal J; Heitmann S; Herzog AL; Wiendl H; Jakob W; Schmidt E; Freivogel K; Dörner T;
    Arthritis Res Ther; 2011 May; 13(3):R75. PubMed ID: 21569519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease.
    Dale RC; Brilot F; Duffy LV; Twilt M; Waldman AT; Narula S; Muscal E; Deiva K; Andersen E; Eyre MR; Eleftheriou D; Brogan PA; Kneen R; Alper G; Anlar B; Wassmer E; Heineman K; Hemingway C; Riney CJ; Kornberg A; Tardieu M; Stocco A; Banwell B; Gorman MP; Benseler SM; Lim M
    Neurology; 2014 Jul; 83(2):142-50. PubMed ID: 24920861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti CD20 (Rituximab) therapy in refractory pediatric rheumatic diseases.
    Reis J; Aguiar F; Brito I
    Acta Reumatol Port; 2016; 41(1):45-55. PubMed ID: 27115107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases.
    Khojah AM; Miller ML; Klein-Gitelman MS; Curran ML; Hans V; Pachman LM; Fuleihan RL
    Pediatr Rheumatol Online J; 2019 Aug; 17(1):61. PubMed ID: 31462263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of Sjögren's syndrome after two infusions of rituximab (anti-CD20).
    Devauchelle-Pensec V; Pennec Y; Morvan J; Pers JO; Daridon C; Jousse-Joulin S; Roudaut A; Jamin C; Renaudineau Y; Roué IQ; Cochener B; Youinou P; Saraux A
    Arthritis Rheum; 2007 Mar; 57(2):310-7. PubMed ID: 17330280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases.
    El-Hallak M; Binstadt BA; Leichtner AM; Bennett CM; Neufeld EJ; Fuhlbrigge RC; Zurakowski D; Sundel RP
    J Pediatr; 2007 Apr; 150(4):376-82. PubMed ID: 17382113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current role of rituximab in systemic lupus erythematosus.
    Mok CC
    Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tocilizumab for refractory organising pneumonia associated with Sjögren's disease.
    Justet A; Ottaviani S; Dieudé P; Taillé C
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25976199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of large refractory pyoderma gangrenosum-like presentation of granulomatosis with polyangiitis by rituximab.
    Sen M; Dogra S; Rathi M; Sharma A
    Int J Rheum Dis; 2017 Dec; 20(12):2200-2202. PubMed ID: 27126548
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical and microbiological characteristics of the infections in patients treated with rituximab for autoimmune and/or malignant hematological disorders.
    Tudesq JJ; Cartron G; Rivière S; Morquin D; Iordache L; Mahr A; Pourcher V; Klouche K; Cerutti D; Le Quellec A; Guilpain P
    Autoimmun Rev; 2018 Feb; 17(2):115-124. PubMed ID: 29180125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential utility of B cell-directed biologic therapy in autoimmune diseases.
    Arkfeld DG
    Rheumatol Int; 2008 Jan; 28(3):205-15. PubMed ID: 17957371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries.
    Mariette X; Gottenberg JE; Ravaud P; Combe B
    Rheumatology (Oxford); 2011 Jan; 50(1):222-9. PubMed ID: 21148156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome.
    Cornec D; Costa S; Devauchelle-Pensec V; Jousse-Joulin S; Marcorelles P; Berthelot JM; Chiche L; Hachulla E; Hatron PY; Goeb V; Vittecoq O; Saraux A; Pers JO
    J Autoimmun; 2016 Feb; 67():102-110. PubMed ID: 26688003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.